Get started
Author

Shang‐Ming Dai

Observed names: Shang-Ming Dai, Shangming Dai
ORCID: 0009-0004-7536-0913
Observed ORCID: 0009-0004-7536-0913
OpenAlex ID: A5016828513
Relationship between miRNA and ferroptosis in tumors
2022 · Shang-Ming Dai, Feng-Jiao Li, et al. · Frontiers in Pharmacology · 58
PDF
The important role of miR-1-3p in cancers
2023 · Shangming Dai, Fengjiao Li, et al. · Journal of Translational Medicine · 30
PDF
Isoliensinine suppressed gastric cancer cell proliferation and migration by targeting TGFBR1 to regulate TGF-β-smad signaling pathways
2024 · Jinda Hu, Shangming Dai, et al. · Frontiers in Pharmacology · 12
PDF
Isoliensinine activated the Nrf2/GPX4 pathway to inhibit glutamate‐induced ferroptosis in HT‐22 cells
2024 · Hui‐Zhi Long, Feng‐Jiao Li, et al. · Journal of Biochemical and Molecular Toxicology · 7
Dihydroisotanshinone I regulates ferroptosis via PI3K/AKT pathway to enhance cisplatin sensitivity in lung adenocarcinoma
2024 · Feng-Jiao Li, Li-Chen Gao, et al. · Journal of Pharmacy and Pharmacology · 5
PDF
Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects
2024 · Hong-Yu Luo, Shuo-Guo Xu, et al. · Drugs in R&D · 1
PDF
Works count: 6
Citation count: 113
H-index: 5
I10-index: 3
Year
Topic
Type